The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak…

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots...

The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.